Clorox (NYSE:CLX – Get Free Report) had its target price dropped by equities research analysts at Jefferies Financial Group from $139.00 to $125.00 in a research note issued to investors on Monday,MarketScreener reports. The firm currently has a “buy” rating on the stock. Jefferies Financial Group’s price objective indicates a potential upside of 46.93% from the stock’s previous close.
Several other research analysts also recently weighed in on the company. TD Cowen upped their target price on Clorox from $98.00 to $111.00 and gave the stock a “hold” rating in a research note on Tuesday, March 31st. Morgan Stanley cut their price objective on Clorox from $110.00 to $97.00 and set an “equal weight” rating for the company in a research note on Friday. Wells Fargo & Company decreased their price objective on Clorox from $110.00 to $100.00 and set an “equal weight” rating on the stock in a report on Friday. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating and set a $91.00 target price on shares of Clorox in a research note on Friday. Finally, Citigroup decreased their price target on shares of Clorox from $110.00 to $97.00 and set a “neutral” rating on the stock in a research note on Friday. One equities research analyst has rated the stock with a Buy rating, twelve have assigned a Hold rating and four have given a Sell rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Reduce” and a consensus price target of $104.00.
Read Our Latest Stock Report on CLX
Clorox Price Performance
Clorox (NYSE:CLX – Get Free Report) last announced its quarterly earnings results on Thursday, April 30th. The company reported $1.64 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.55 by $0.09. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The firm had revenue of $1.67 billion for the quarter, compared to the consensus estimate of $1.67 billion. During the same period in the prior year, the firm posted $1.45 earnings per share. The firm’s quarterly revenue was up .1% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. Equities research analysts forecast that Clorox will post 5.56 EPS for the current year.
Institutional Trading of Clorox
Hedge funds and other institutional investors have recently modified their holdings of the business. Center for Financial Planning Inc. acquired a new position in Clorox in the third quarter valued at about $25,000. Vermillion & White Wealth Management Group LLC purchased a new position in shares of Clorox during the 3rd quarter worth approximately $25,000. Caitlin John LLC boosted its position in shares of Clorox by 1,807.1% during the 4th quarter. Caitlin John LLC now owns 267 shares of the company’s stock worth $27,000 after purchasing an additional 253 shares during the period. Root Financial Partners LLC acquired a new stake in Clorox in the 3rd quarter valued at approximately $29,000. Finally, Darwin Wealth Management LLC acquired a new position in Clorox during the 2nd quarter worth about $29,000. 78.53% of the stock is owned by institutional investors and hedge funds.
About Clorox
The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.
Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.
Further Reading
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.
